Loading insider details...
Beta
Latest Form 4 (Sep 26, 2026): Grant/Award of 2,000 NKTR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 26, 2026 | NEKTAR THERAPEUTICS (NKTR) | Grant/Award | 2,000 | n/a |
| Oct 1, 2025 | NEKTAR THERAPEUTICS (NKTR) | Grant/Award | 8,000 | n/a |
| Sep 22, 2023 | NEKTAR THERAPEUTICS (NKTR) | Grant/Award | 85,000 | n/a |
| Sep 21, 2022 | NEKTAR THERAPEUTICS (NKTR) | Grant/Award | 10,200 | n/a |
| Nov 9, 2021 | NEKTAR THERAPEUTICS (NKTR) | Exercise/Conversion | 12,500 | $160.0K |
| Sep 24, 2021 | NEKTAR THERAPEUTICS (NKTR) | Grant/Award | 10,200 | n/a |
| Aug 31, 2021 | NEKTAR THERAPEUTICS (NKTR) | Exercise/Conversion | 45,000 | $571.5K |
| May 12, 2021 | Inogen Inc (INGN) | Grant/Award | 2,754 | n/a |
| Feb 5, 2021 | Inogen Inc (INGN) | Exercise/Conversion | 6,666 | $311.0K |
| Jan 5, 2021 | NEKTAR THERAPEUTICS (NKTR) | Exercise/Conversion | 40,000 | $552.0K |